FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995205917> ?p ?o ?g. }

• W1995205917 endingPage "314" @default.
• W1995205917 startingPage "305" @default.
• W1995205917 abstract "Aim The increase of prostate-specific antigen (PSA) after radical retropubic prostatectomy (RP) or external beam radiotherapy (EBRT) is the most sensitive tool for detecting prostate cancer (PCa) recurrence, although this measure cannot distinguish between local, regional, or distant recurrence. The aim of this meta-analysis was to evaluate the diagnostic performance of 18F-choline and 11C-choline PET or PET/CT in detection of locoregional or distant metastases in PCa. Materials and Methods Medline, Web of Knowledge, and Google Scholar search was carried out in order to select English-language articles dealing with diagnostic performance of both 18F-choline and 11C-choline PET for the detection of PCa recurrence after RP or EBRT. Articles were included only if absolute numbers of true-positive, true-negative, false-positive, and false-negative test results were available or derivable from the text and regarded local, lymph node, and distant metastases. Reviews, clinical reports, and editorial articles were excluded. All complete studies were re-analyzed thus performing a quantitative analysis. Results From the years 2000 to 2012, we found 53 complete articles that critically evaluated the role of choline PET in restaging patients with PCa recurrence. The meta-analysis was carried out and dealt with 19 selected studies (12 studies for all sites of disease, 3 for lymph node metastases, and 4 for local recurrence), with a total of 1555 patients. The meta-analysis provided a pooled sensitivity of 85.6% (95% CI: 82.9%–88.1%) and pooled specificity of 92.6% (95% CI: 90.1%–94.6%) for all sites of disease (prostatic fossa, lymph nodes, and bone), a pooled sensitivity of 75.4% (95% CI: 66.9%–82.6%) and pooled specificity of 82% (95% CI: 68.6%–91.4%) for prostatic fossa recurrence, and a pooled sensitivity of 100% (95% CI: 90.5%–100%) and pooled specificity of 81.8% (95% CI: 48.2%–97.7%) for lymph node metastases. The heterogeneity ranged between 0.00% and 88.6%. The diagnostic odds ratios were 62.123 (95% CI: 24.783–155.72), 5.869 (95% CI: 1.818–18.946), and 138.57 (95% CI: 11.27–1703.8), respectively, for all sites of disease, local recurrence, and lymph node disease. Conclusions Choline PET and PET/CT represent high sensitivity and specificity techniques for the detection of locoregional and distant metastases in PCa patients with recurrence of disease. Moreover, a high diagnostic odds ratio was found for the identification of lymph node disease in patients with biochemical recurrence of PCa." @default.
• W1995205917 created "2016-06-24" @default.
• W1995205917 creator A5010421937 @default.
• W1995205917 creator A5025420395 @default.
• W1995205917 creator A5038225071 @default.
• W1995205917 creator A5059462029 @default.
• W1995205917 creator A5063598688 @default.
• W1995205917 creator A5083483292 @default.
• W1995205917 creator A5087431312 @default.
• W1995205917 date "2013-05-01" @default.
• W1995205917 modified "2023-10-02" @default.
• W1995205917 title "Choline PET or PET/CT and Biochemical Relapse of Prostate Cancer" @default.
• W1995205917 cites W118242009 @default.
• W1995205917 cites W1569018819 @default.
• W1995205917 cites W1965751182 @default.
• W1995205917 cites W1967551217 @default.
• W1995205917 cites W1971005131 @default.
• W1995205917 cites W1972606661 @default.
• W1995205917 cites W1982447130 @default.
• W1995205917 cites W1985132878 @default.
• W1995205917 cites W1985799860 @default.
• W1995205917 cites W1990235169 @default.
• W1995205917 cites W1991291077 @default.
• W1995205917 cites W1994970959 @default.
• W1995205917 cites W1997575310 @default.
• W1995205917 cites W1999409811 @default.
• W1995205917 cites W2002301736 @default.
• W1995205917 cites W2004416308 @default.
• W1995205917 cites W2006088278 @default.
• W1995205917 cites W2008261889 @default.
• W1995205917 cites W2011003253 @default.
• W1995205917 cites W2019026418 @default.
• W1995205917 cites W2020883234 @default.
• W1995205917 cites W2030040160 @default.
• W1995205917 cites W2033238186 @default.
• W1995205917 cites W2039467174 @default.
• W1995205917 cites W2039499300 @default.
• W1995205917 cites W2040370548 @default.
• W1995205917 cites W2040659915 @default.
• W1995205917 cites W2042152896 @default.
• W1995205917 cites W2043839162 @default.
• W1995205917 cites W2044196464 @default.
• W1995205917 cites W2047784025 @default.
• W1995205917 cites W2047959734 @default.
• W1995205917 cites W2049456541 @default.
• W1995205917 cites W2049850563 @default.
• W1995205917 cites W2052766723 @default.
• W1995205917 cites W2061595656 @default.
• W1995205917 cites W2065013125 @default.
• W1995205917 cites W2073380728 @default.
• W1995205917 cites W2081982276 @default.
• W1995205917 cites W2085776136 @default.
• W1995205917 cites W2094702812 @default.
• W1995205917 cites W2117766622 @default.
• W1995205917 cites W2125435699 @default.
• W1995205917 cites W2134640294 @default.
• W1995205917 cites W2137698336 @default.
• W1995205917 cites W2147493587 @default.
• W1995205917 cites W2154974136 @default.
• W1995205917 cites W2159511117 @default.
• W1995205917 cites W2160771508 @default.
• W1995205917 cites W2163863351 @default.
• W1995205917 cites W2169160087 @default.
• W1995205917 cites W2396567433 @default.
• W1995205917 cites W2470836458 @default.
• W1995205917 cites W3215447 @default.
• W1995205917 cites W4241174091 @default.
• W1995205917 cites W4245681340 @default.
• W1995205917 cites W4300900655 @default.
• W1995205917 cites W69788875 @default.
• W1995205917 doi "https://doi.org/10.1097/rlu.0b013e3182867f3c" @default.
• W1995205917 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23486334" @default.
• W1995205917 hasPublicationYear "2013" @default.
• W1995205917 type Work @default.
• W1995205917 sameAs 1995205917 @default.
• W1995205917 citedByCount "258" @default.
• W1995205917 countsByYear W19952059172013 @default.
• W1995205917 countsByYear W19952059172014 @default.
• W1995205917 countsByYear W19952059172015 @default.
• W1995205917 countsByYear W19952059172016 @default.
• W1995205917 countsByYear W19952059172017 @default.
• W1995205917 countsByYear W19952059172018 @default.
• W1995205917 countsByYear W19952059172019 @default.
• W1995205917 countsByYear W19952059172020 @default.
• W1995205917 countsByYear W19952059172021 @default.
• W1995205917 countsByYear W19952059172022 @default.
• W1995205917 countsByYear W19952059172023 @default.
• W1995205917 crossrefType "journal-article" @default.
• W1995205917 hasAuthorship W1995205917A5010421937 @default.
• W1995205917 hasAuthorship W1995205917A5025420395 @default.
• W1995205917 hasAuthorship W1995205917A5038225071 @default.
• W1995205917 hasAuthorship W1995205917A5059462029 @default.
• W1995205917 hasAuthorship W1995205917A5063598688 @default.
• W1995205917 hasAuthorship W1995205917A5083483292 @default.
• W1995205917 hasAuthorship W1995205917A5087431312 @default.
• W1995205917 hasConcept C121608353 @default.
• W1995205917 hasConcept C126322002 @default.
• W1995205917 hasConcept C126838900 @default.

• next